Healthcare / Medical Care FacilitiesThailand
$5.80
-0.05 (-0.85%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $169.6M · quality 85.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.8B
P/E
13.5x
↓EV/EBITDA
6.7x
↓ROE
7.6%
↑Gross Margin
55.7%
↑Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.1%
FCF CAGR
-2.0%
FCF margin
23.6%
FCF / Net income
1.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $701.9M · net income $131.1M · FCF $165.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $701.9M | $701.9M | $830.1M | $848.6M | $726.6M |
| Net Income | $131.1M | $131.1M | $167.1M | $201.8M | $161.9M |
| EBITDA | $212.3M | $212.3M | $279.1M | $309.7M | $270.9M |
| EPS | 0.43 | 0.43 | 0.55 | 0.77 | 0.53 |
| Gross Margin | 55.7% | 55.7% | 55.1% | 55.3% | 54.7% |
| Operating Margin | 20.9% | 20.9% | 24.5% | 28.6% | 28.0% |
| Net Margin | 18.7% | 18.7% | 20.1% | 23.8% | 22.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 |
| Current Ratio | 15.61 | 15.61 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $165.8M | $165.8M | $188.5M | $169.6M | $176.0M |
| Returns | |||||
| ROE | 7.6% | 7.6% | 9.4% | 12.2% | 13.4% |
| Valuation | |||||
| P/E | 13.49 | 13.49 | 22.55 | 23.90 | — |
| EV/EBITDA | 6.69 | 6.69 | 9.86 | 11.87 | — |
| P/B | 1.03 | 1.03 | 2.12 | 2.92 | — |
| Growth & Yield | |||||
| Revenue Growth | -15.4% | -15.4% | -2.2% | 16.8% | — |
| EPS Growth | -21.8% | -21.8% | -28.6% | 44.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.2%
EPS terminal req.
$0.51
Spread vs growth
-28.0%
5Y implied EPS CAGR
7.7%
EPS terminal req.
$0.62
Spread vs growth
-29.5%
10Y implied EPS CAGR
8.8%
EPS terminal req.
$1.00
Spread vs growth
-30.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-34.5%
Start / end P/E
16.1x → 13.5x
EPS bridge
0.55 → 0.43
Residual
+3.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.